Benchling for Antibody R&D
Aug 24, 2021
Innovations in monoclonal antibody technology, bispecifics, and antibody-drug conjugates continue to push the envelope of antibody efficacy and safety. But the industry requires a new kind of digital solution that can offer a holistic view of antibody research and development, integrating large and disparate data sets to extract timely insights, while providing complete traceability to sequences, cell lines, and production processes. Learn how Benchling improves antibody R&D productivity and increases collaboration by 95%.
Benchling for Antibody R&D.pdf
- Radiolabelling Nucleic Acids with [γ-32P] ATP for Analytical Assays
- Generating and maintaining uniform 3D spheroids in long term cultures
- Noninvasive 3D imaging Using Optical Coherence Tomography
- Streamlined High Throughput Drug Screening with PrimeSurface® White 384 well 3D plates